2021 Q4 Form 10-K Financial Statement

#000095017022003603 Filed on March 14, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021
Revenue $41.50M $159.0M
YoY Change 10.84% 9.66%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.230M $1.210M $6.519M
YoY Change -53.58% -43.19% -15.49%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $7.426M $31.14M
YoY Change -11.43% -8.82%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $27.91M $22.89M $81.87M
YoY Change 158.43% -180.56% -321.39%
Income Tax $7.640M $6.167M $24.22M
% Of Pretax Income 27.37% 26.94% 29.58%
Net Earnings $19.47M $15.94M $54.11M
YoY Change 200.93% -167.46% -255.56%
Net Earnings / Revenue 38.41% 34.04%
Basic Earnings Per Share $0.65 $2.20
Diluted Earnings Per Share $780.7K $0.64 $2.17
COMMON SHARES
Basic Shares Outstanding 25.08M 24.63M 24.60M
Diluted Shares Outstanding 24.99M 24.94M

Balance Sheet

Concept 2021 Q4 2021 Q3 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $109.3M $78.20M
YoY Change 7.6%
Cash & Equivalents $64.48M $30.69M
Short-Term Investments $44.77M $47.51M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $11.80M $11.70M $11.80M
YoY Change -4.84% -7.14% -4.84%
Goodwill $150.8M $150.8M
YoY Change 0.0% 0.0%
Intangibles $23.48M $50.01M
YoY Change -54.04% -2.81%
Long-Term Investments $9.726M $0.00 $9.700M
YoY Change -0.21% -100.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.873B $1.805B $1.873B
YoY Change 14.04% 12.53% 14.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.400M $3.000M $3.400M
YoY Change -27.66% -21.05% -27.66%
Accrued Expenses $11.20M $11.50M $11.20M
YoY Change -13.85% -12.88% -13.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $8.054M
YoY Change -100.0% -90.82%
Long-Term Debt Due $0.00 $8.100M $0.00
YoY Change -100.0% -90.76% -100.0%
Total Short-Term Liabilities $24.80M $40.60M $24.80M
YoY Change -78.09% -67.39% -76.38%
LONG-TERM LIABILITIES
Long-Term Debt $220.0M $213.9M $220.0M
YoY Change 43.14% 76.49% 43.14%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $220.0M $213.9M $220.0M
YoY Change 43.14% 76.49% 43.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.80M $40.60M $24.80M
Total Long-Term Liabilities $220.0M $213.9M $220.0M
Total Liabilities $1.517B $1.467B $1.586B
YoY Change 13.41% 12.21% 12.4%
SHAREHOLDERS EQUITY
Retained Earnings $30.61M $11.14M
YoY Change -230.23% -137.16%
Common Stock $280.3M $279.7M
YoY Change 0.9% 0.88%
Preferred Stock
YoY Change
Treasury Stock (at cost) $24.92M $24.92M
YoY Change 0.0% 0.0%
Treasury Stock Shares $2.951M $2.951M
Shareholders Equity $287.0M $267.2M $287.0M
YoY Change
Total Liabilities & Shareholders Equity $1.873B $1.805B $1.873B
YoY Change 14.04% 12.53% 14.05%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021
OPERATING ACTIVITIES
Net Income $19.47M $15.94M $54.11M
YoY Change 200.93% -167.46% -255.56%
Depreciation, Depletion And Amortization $1.230M $1.210M $6.519M
YoY Change -53.58% -43.19% -15.49%
Cash From Operating Activities $16.75M $22.16M $78.73M
YoY Change -24.35% -4.36% 0.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$36.19M -$70.32M -$238.3M
YoY Change -5667.69% 37.45% 39.4%
Cash From Investing Activities -$36.19M -$70.32M -$238.3M
YoY Change -5667.69% 37.45% 39.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 58.56M 41.98M 172.0M
YoY Change 48.18% -260.47% 26.06%
NET CHANGE
Cash From Operating Activities 16.75M 22.16M 78.73M
Cash From Investing Activities -36.19M -70.32M -238.3M
Cash From Financing Activities 58.56M 41.98M 172.0M
Net Change In Cash 39.12M -6.180M 12.44M
YoY Change -37.22% -88.59% -71.86%
FREE CASH FLOW
Cash From Operating Activities $16.75M $22.16M $78.73M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.medallion.com/20211231#PropertyEquipmentAndRightOfUseAssetNet
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.medallion.com/20211231#PropertyEquipmentAndRightOfUseAssetNet
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent
CY2021Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-02-28
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent
CY2020 us-gaap Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
2021-02-28
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001000209
CY2020 us-gaap Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
2021-09-30
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-37747
CY2021 dei Entity Registrant Name
EntityRegistrantName
MEDALLION FINANCIAL CORP
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3291176
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
437 MADISON AVENUE, 38th Floor
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2021 dei City Area Code
CityAreaCode
212
CY2021 dei Local Phone Number
LocalPhoneNumber
328-2100
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2021 dei Trading Symbol
TradingSymbol
MFIN
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
182908826000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25543325
CY2021 dei Auditor Firm
AuditorFirmId
339
CY2021 dei Auditor Name
AuditorName
Mazars USA LLP
CY2021 dei Auditor Location
AuditorLocation
New York, New York
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64482000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54743000
CY2021Q4 us-gaap Federal Funds Sold
FederalFundsSold
60002000
CY2020Q4 us-gaap Federal Funds Sold
FederalFundsSold
57297000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
44772000
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
46792000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9726000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9746000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1488924000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1229838000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50166000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57548000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1438758000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1172290000
CY2021Q4 us-gaap Goodwill
Goodwill
150803000
CY2020Q4 us-gaap Goodwill
Goodwill
150803000
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
37430000
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
54560000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23480000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51090000
CY2021Q4 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
11762000
CY2020Q4 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
12404000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
10621000
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
10338000
CY2021Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
833000
CY2020Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
1757000
CY2021Q4 us-gaap Other Assets
OtherAssets
20388000
CY2020Q4 us-gaap Other Assets
OtherAssets
20591000
CY2021Q4 us-gaap Assets
Assets
1873057000
CY2020Q4 us-gaap Assets
Assets
1642411000
CY2021Q4 us-gaap Deposits
Deposits
1250880000
CY2020Q4 us-gaap Deposits
Deposits
1065398000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
219973000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
153718000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18210000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
807000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9053000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11018000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3395000
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4673000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
87334000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
15718000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
14902000
CY2021Q4 us-gaap Liabilities
Liabilities
1517229000
CY2020Q4 us-gaap Liabilities
Liabilities
1337850000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28124629
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27828871
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
281000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
278000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
280038000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
277539000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2951243
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2951243
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24919000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24919000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1034000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2012000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30606000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23502000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
287040000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
231408000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
68788000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
73153000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
355828000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
304561000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1873057000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1642411000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25173386
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24877628
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.40
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.30
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
3000000.0
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
3000000.0
CY2021Q4 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
7400000
CY2020Q4 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
3500000
CY2021Q4 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2200000
CY2020Q4 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2000000.0
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
157990000
CY2020 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
143701000
CY2019 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
130167000
CY2021 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
976000
CY2020 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
1208000
CY2019 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
2225000
CY2021 us-gaap Lease Income
LeaseIncome
0
CY2020 us-gaap Lease Income
LeaseIncome
53000
CY2019 us-gaap Lease Income
LeaseIncome
170000
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
158966000
CY2020 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
144962000
CY2019 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
132562000
CY2021 us-gaap Interest Expense Deposits
InterestExpenseDeposits
17543000
CY2020 us-gaap Interest Expense Deposits
InterestExpenseDeposits
22330000
CY2019 us-gaap Interest Expense Deposits
InterestExpenseDeposits
22521000
CY2021 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
690000
CY2020 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
2006000
CY2019 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
3242000
CY2021 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
12907000
CY2020 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
9815000
CY2019 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
9282000
CY2021 us-gaap Interest Expense
InterestExpense
31140000
CY2020 us-gaap Interest Expense
InterestExpense
34151000
CY2019 us-gaap Interest Expense
InterestExpense
35045000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
127826000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
110811000
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
97517000
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4622000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
69817000
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
47386000
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
123204000
CY2020 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
40994000
CY2019 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
50131000
CY2021 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
12567000
CY2020 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
20042000
CY2019 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
18742000
CY2021 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
17379000
CY2020 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-2985000
CY2019 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0
CY2021 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
5592000
CY2020 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
24523000
CY2019 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
-4381000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4626000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4145000
CY2021 us-gaap Noninterest Income Other
NoninterestIncomeOther
2586000
CY2020 us-gaap Noninterest Income Other
NoninterestIncomeOther
1530000
CY2019 us-gaap Noninterest Income Other
NoninterestIncomeOther
1881000
CY2021 us-gaap Noninterest Income
NoninterestIncome
31566000
CY2020 us-gaap Noninterest Income
NoninterestIncome
-5936000
CY2019 us-gaap Noninterest Income
NoninterestIncome
20387000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
31591000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
28172000
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
24971000
CY2021 mfin Race Team Related Expense
RaceTeamRelatedExpense
9559000
CY2020 mfin Race Team Related Expense
RaceTeamRelatedExpense
8366000
CY2019 mfin Race Team Related Expense
RaceTeamRelatedExpense
8996000
CY2021 mfin Loan Servicing Fee
LoanServicingFee
7013000
CY2020 mfin Loan Servicing Fee
LoanServicingFee
6737000
CY2019 mfin Loan Servicing Fee
LoanServicingFee
5253000
CY2021 us-gaap Professional Fees
ProfessionalFees
5311000
CY2020 us-gaap Professional Fees
ProfessionalFees
8047000
CY2019 us-gaap Professional Fees
ProfessionalFees
7402000
CY2021 mfin Collection Costs
CollectionCosts
5279000
CY2020 mfin Collection Costs
CollectionCosts
5454000
CY2019 mfin Collection Costs
CollectionCosts
6638000
CY2021 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
2454000
CY2020 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
2833000
CY2019 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
2419000
CY2021 mfin Regulatory Fees
RegulatoryFees
1872000
CY2020 mfin Regulatory Fees
RegulatoryFees
1822000
CY2019 mfin Regulatory Fees
RegulatoryFees
1722000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1445000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1445000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1446000
CY2021 mfin Travel Meals And Entertainment Expense
TravelMealsAndEntertainmentExpense
634000
CY2020 mfin Travel Meals And Entertainment Expense
TravelMealsAndEntertainmentExpense
375000
CY2019 mfin Travel Meals And Entertainment Expense
TravelMealsAndEntertainmentExpense
1138000
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
7741000
CY2020 us-gaap Other Noninterest Expense
OtherNoninterestExpense
8788000
CY2019 us-gaap Other Noninterest Expense
OtherNoninterestExpense
8196000
CY2021 us-gaap Noninterest Expense
NoninterestExpense
72899000
CY2020 us-gaap Noninterest Expense
NoninterestExpense
72039000
CY2019 us-gaap Noninterest Expense
NoninterestExpense
68181000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81871000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36981000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2337000
CY2021 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
24217000
CY2020 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
-10074000
CY2019 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
341000
CY2021 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
57654000
CY2020 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
-26907000
CY2019 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
1996000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3546000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3546000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7876000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3758000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
54108000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-34783000
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7876000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24599804
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24445452
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24342979
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24943169
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24445452
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-1762000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.20
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.42
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.17
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24342979
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
800000
CY2020 us-gaap Paid In Kind Interest
PaidInKindInterest
1200000
CY2019 us-gaap Paid In Kind Interest
PaidInKindInterest
800000
CY2021 mfin Average Borrowings Outstanding
AverageBorrowingsOutstanding
1370700
CY2020 mfin Average Borrowings Outstanding
AverageBorrowingsOutstanding
1258500000
CY2019 mfin Average Borrowings Outstanding
AverageBorrowingsOutstanding
1138700000
CY2021 mfin Weighted Average Cost Of Borrowings
WeightedAverageCostOfBorrowings
0.0228
CY2020 mfin Weighted Average Cost Of Borrowings
WeightedAverageCostOfBorrowings
0.0271
CY2019 mfin Weighted Average Cost Of Borrowings
WeightedAverageCostOfBorrowings
0.0308
CY2021 us-gaap Profit Loss
ProfitLoss
57654000
CY2020 us-gaap Profit Loss
ProfitLoss
-26907000
CY2019 us-gaap Profit Loss
ProfitLoss
1996000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-978000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1013000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1081000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
56676000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-25894000
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3077000
CY2019 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3758000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53130000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33770000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-681000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
290204000
CY2019 us-gaap Profit Loss
ProfitLoss
1996000
CY2019 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
42485000
CY2019 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-2519000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1221000
CY2019 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
1081000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
334468000
CY2020 us-gaap Profit Loss
ProfitLoss
-26907000
CY2020 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-6043000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2030000
CY2020 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
1013000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
304561000
CY2021 us-gaap Profit Loss
ProfitLoss
57654000
CY2021 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-6516000
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-1395000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2261000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
241000
CY2021 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-978000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
355828000
CY2021 us-gaap Profit Loss
ProfitLoss
57654000
CY2020 us-gaap Profit Loss
ProfitLoss
-26907000
CY2019 us-gaap Profit Loss
ProfitLoss
1996000
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4622000
CY2020 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
69817000
CY2019 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
47386000
CY2021 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
814000
CY2020 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
1188000
CY2019 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
834000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6519000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7714000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7499000
CY2021 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-7996000
CY2020 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-6022000
CY2019 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-4952000
CY2021 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
18327000
CY2020 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-8776000
CY2019 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
853000
CY2021 mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-8966000
CY2020 mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-31926000
CY2019 mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-11838000
CY2021 mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
17380000
CY2020 mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
-4305000
CY2020 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
1676000
CY2019 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
1249000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
715000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5354000
CY2019 mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
1820000
CY2021 mfin Net Change In Unrealized Depreciation On Investments Operating Activities
NetChangeInUnrealizedDepreciationOnInvestmentsOperatingActivities
0
CY2019 mfin Net Change In Unrealized Depreciation On Investments Operating Activities
NetChangeInUnrealizedDepreciationOnInvestmentsOperatingActivities
1734000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2261000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2030000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1221000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4626000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4145000
CY2021 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
283000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2223000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2838000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2694000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7206000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8024000
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1141000
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
422000
CY2019 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
690000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78726000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78706000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
64935000
CY2021 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
760790000
CY2020 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
506106000
CY2019 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
471069000
CY2021 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
464448000
CY2020 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
321831000
CY2019 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
251653000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19354000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
15580000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10507000
CY2021 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
17676000
CY2021 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
35647000
CY2020 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
15399000
CY2019 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
7119000
CY2021 mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
24052000
CY2020 mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
13499000
CY2019 mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
16294000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-238321000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-170957000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-206510000
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
805577000
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
668577000
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
525842000
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
526064000
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
627263000
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
414277000
CY2021 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
0
CY2019 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
4000000
CY2021 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
CY2019 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
4000000
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
42485000
CY2021 mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
6516000
CY2020 mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
6043000
CY2019 mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
2367000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
241000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
172039000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
136470000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
151683000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12444000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44219000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10108000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
112040000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67821000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57713000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
124484000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
112040000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67821000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
29867000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
31204000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
32008000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5479000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
104000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
310000
CY2021 mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
15888000
CY2020 mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
47254000
CY2019 mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
31348000
CY2021 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
0
CY2020 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
1800000
CY2021 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
8700000
CY2021 mfin Number Of Medallions
NumberOfMedallions
159
CY2021Q4 us-gaap Reorganization Value Net Realizable Value Of Asset Dispositions
ReorganizationValueNetRealizableValueOfAssetDispositions
1000000.0
CY2020Q4 us-gaap Reorganization Value Net Realizable Value Of Asset Dispositions
ReorganizationValueNetRealizableValueOfAssetDispositions
2900000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the US, or GAAP, requires management to make estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions change, it is reasonably possible that</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">judgments and estimates could change, which may result in future impairments of loans and loan collateral in process of foreclosure, goodwill and intangible assets, and investments, among other effects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1300000
CY2021Q4 mfin Non Marketable Securities
NonMarketableSecurities
9700000
CY2020Q4 mfin Non Marketable Securities
NonMarketableSecurities
9700000
CY2021 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
800000
CY2021 mfin Percentage Of Investments Sold
PercentageOfInvestmentsSold
0.80
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12500000
CY2021 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
11300000
CY2021Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
300
CY2021 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-50000
CY2021 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2021 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-50000
CY2021 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
100000
CY2020 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
300000
CY2019 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
100000
CY2021 mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
26100000
CY2020 mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
20700000
CY2021 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
7700000
CY2020 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
-6000000.0
CY2019 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
-5000000.0
CY2021 mfin Financing Receivables Impaired Troubled Debt Restructuring Write Down As Percentage Of Loans
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDownAsPercentageOfLoans
0.40
CY2021Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
0
CY2020Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
15400000
CY2021Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
20500000
CY2020Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
107100000
CY2021 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2020Q4 us-gaap Goodwill
Goodwill
150800000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23500000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51100000
CY2021Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
26200000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2021 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
54108000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23480000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51090000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
400000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
400000
CY2020 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2600000
CY2019 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2300000
CY2021Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7100000
CY2020Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
5800000
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.17
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.20
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.42
CY2020 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
-34783000
CY2019 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
-1762000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24599804
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24445452
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24342979
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
92602
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
250763
CY2020 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2019 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24943169
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24445452
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24342979
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
421190
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
934003
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
462180
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
317398
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
444557
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
449450
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2300000
CY2020 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2000000.0
CY2019 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1200000
CY2021 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.09
CY2020 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.08
CY2019 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.05
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3000000.0
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P13M
CY2021Q4 mfin Tier One Leverage Capital Required For Capital Adequacy To Total Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToTotalAssets
0.15
CY2021Q4 mfin Tier One Leverage Capital Ratio
TierOneLeverageCapitalRatio
0.1753
CY2021Q4 mfin Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.065
CY2021Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
13.1
CY2021Q4 mfin Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.070
CY2021Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
193459000
CY2020Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
148507000
CY2021Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
262247000
CY2020Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
217295000
CY2021Q4 us-gaap Capital
Capital
281211000
CY2020Q4 us-gaap Capital
Capital
233460000
CY2021 mfin Average Assets
AverageAssets
1495726000
CY2020 mfin Average Assets
AverageAssets
1283664000
CY2021Q4 us-gaap Risk Weighted Assets
RiskWeightedAssets
1482678000
CY2020Q4 us-gaap Risk Weighted Assets
RiskWeightedAssets
1243783000
CY2021Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
4.0
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
5.0
CY2021Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
17.5
CY2020Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
16.9
CY2020Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
11.9
CY2021Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
8.5
CY2021Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
8.0
CY2021Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
17.7
CY2020Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
17.5
CY2021Q4 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
10.5
CY2021Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
10.0
CY2021Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
19.0
CY2020Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
18.8
CY2021 mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain reclassifications have been made to prior year balances to conform with the current year presentation. These reclassifications have no effect on the previously reported results of operations.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
44494000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
732000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
454000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
44772000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
45155000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1684000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
47000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
46792000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
10000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
10000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
9907000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
10107000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
9919000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
10107000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
24658000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
24548000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
44494000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
44772000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
412000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
18454000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
42000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1956000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
45000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
4028000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
196000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57548000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
46093000
CY2021 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-32948000
CY2020 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
75844000
CY2021 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
20944000
CY2020Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0468
CY2020Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
0.9317
CY2021Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
35571000
CY2020Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
61767000
CY2020 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
17482000
CY2021 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
-12004000
CY2020 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
58362000
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4622000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
69817000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50166000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57548000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50166000
CY2021Q4 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2021Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0337
CY2021Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
1.4103
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57548000
CY2020Q4 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2019Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
26484000
CY2021 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
1620000
CY2020 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
3311000
CY2019 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
2152000
CY2021 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
432000
CY2020 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
602000
CY2019 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
254000
CY2021 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
3623000
CY2020 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
5252000
CY2019 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
2744000
CY2021 mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
942000
CY2020 mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
792000
CY2019 mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
471000
CY2021Q4 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.024
CY2020Q4 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.050
CY2019Q4 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.020
CY2021Q4 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
1.410
CY2020Q4 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
0.930
CY2019Q4 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
1.740
CY2021Q4 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1488924000
CY2021 mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0242
CY2020Q4 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1229838000
CY2020 mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0506
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
36065000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
37007000
CY2021Q4 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
10168000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
62174000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
62778000
CY2020Q4 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
25310000
CY2021 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
40080000
CY2021 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
608000
CY2020 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
65933000
CY2020 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
1150000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
41761000
CY2021Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1461622000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2021Q4 us-gaap Federal Home Loan Bank Advances Premium
FederalHomeLoanBankAdvancesPremium
500000
CY2021 mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
26800000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
40541000
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1205776000
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2020Q4 us-gaap Federal Home Loan Bank Advances Premium
FederalHomeLoanBankAdvancesPremium
2700000
CY2020 mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
21300000
CY2021Q4 mfin Loan To Value Ratio
LoanToValueRatio
2.95
CY2020Q4 mfin Loan To Value Ratio
LoanToValueRatio
3.27
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
54560000
CY2021 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
15888000
CY2021 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-9879000
CY2021 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-14173000
CY2021 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-8966000
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
37430000
CY2019Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
52711000
CY2020 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
47274000
CY2020 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-7812000
CY2020 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-5687000
CY2020 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-31926000
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
54560000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
405311000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
247965000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
339648000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
179798000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
194779000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
109750000
CY2021Q4 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1477251000
CY2020Q4 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1312005000
CY2021Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0182
CY2021Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7100000
CY2020Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
5800000
CY2021Q4 mfin Reserve Deposits
ReserveDeposits
800000
CY2020Q4 mfin Reserve Deposits
ReserveDeposits
300000
CY2021 mfin Number Of Individual With Time Deposits Greater Than100000
NumberOfIndividualWithTimeDepositsGreaterThan100000
0
CY2021Q4 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
8700000
CY2020Q4 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
1000000.0
CY2021Q4 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Or Less
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsOrLess
119027000
CY2021Q4 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Through Six Months
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsThroughSixMonths
168243000
CY2021Q4 us-gaap Contractual Maturities Time Deposits100000 Or More Six Months Through12 Months
ContractualMaturitiesTimeDeposits100000OrMoreSixMonthsThrough12Months
118041000
CY2021Q4 us-gaap Contractual Maturities Time Deposits100000 Or More After12 Months
ContractualMaturitiesTimeDeposits100000OrMoreAfter12Months
847977000
CY2021Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
1253288000
CY2021 mfin Debt Instrument Maturity Year
DebtInstrumentMaturityYear
2021
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25000000.0
CY2020Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-09-24
CY2021Q4 mfin Remaining Amount Of Debenture After Deducting Leverage Fee
RemainingAmountOfDebentureAfterDeductingLeverageFee
4800000
CY2007Q4 us-gaap Payments For Repurchase Of Trust Preferred Securities
PaymentsForRepurchaseOfTrustPreferredSecurities
2000000.0
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
2287000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2384000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
2184000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2454000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
2821000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
2419000
CY2021 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-118000
CY2020 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
251000
CY2019 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2413000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10045000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11737000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2159000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2004000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9053000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11018000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11212000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13022000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M24D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2439000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2356000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2373000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2390000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2408000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1164000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13130000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1918000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11212000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
43894000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
44799000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
11057000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
19556000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12167000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30493000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
2579000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1174000
CY2021Q4 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
2176000
CY2020Q4 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
-6769000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
15915000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
345000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2295000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
462000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
18210000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
807000
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
1800000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3550000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1563000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
260000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-519000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
13686000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-7702000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
489000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
5418000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2632000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
371000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24217000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10074000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
341000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
17193000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7766000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
642000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3363000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1518000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
120000
CY2021 mfin Income Tax Rate Reconciliation Revaluation Of Net Operating Losses
IncomeTaxRateReconciliationRevaluationOfNetOperatingLosses
1833000
CY2020 mfin Income Tax Rate Reconciliation Revaluation Of Net Operating Losses
IncomeTaxRateReconciliationRevaluationOfNetOperatingLosses
-1228000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10074000
CY2019 mfin Income Tax Rate Reconciliation Revaluation Of Net Operating Losses
IncomeTaxRateReconciliationRevaluationOfNetOperatingLosses
-380000
CY2021 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
1691000
CY2020 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
405000
CY2019 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
251000
CY2021 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
628000
CY2020 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
460000
CY2019 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
309000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
178000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
453000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
0
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
587000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
40000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
17000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24217000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
341000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1111687
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
320922
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0097
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0123
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0229
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0066
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5398
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5103
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4903
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
144666
CY2018Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2018Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
13.84
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.23
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.61
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
44076
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.00
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePrice
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
550040
CY2019Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2019Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
13.53
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.58
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
444557
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.24
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
42928
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.91
CY2020 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
951669
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.41
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
317398
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.79
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
113310
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.64
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44070
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.58
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1111687
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.41
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
62778
CY2019Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit
2.14
CY2019Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit
13.53
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.60
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
178307
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit
2.14
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit
12.55
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.33
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
320922
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit
2.14
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit
12.55
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.53
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
100
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
100
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y25D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
773362
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.42
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
317398
CY2021 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Grants In Period Exercise Price Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsGrantsInPeriodExercisePricePerShare
6.79
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.79
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
106717
CY2021 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit
4.89
CY2021 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
7.25
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
6.41
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
193278
CY2021 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit
5.58
CY2021 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit
7.25
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.63
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
790765
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.52
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
100000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
100000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
100000
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
6
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2021 mfin Number Of Non Operating Segments
NumberOfNonOperatingSegments
2
CY2021 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
158966000
CY2021 mfin Interest Expense Net
InterestExpenseNet
31140000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
127826000
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4622000
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
123204000
CY2021 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
12567000
CY2021 mfin Race Team Related Expense
RaceTeamRelatedExpense
9559000
CY2021 mfin Non Interest Expense Income
NonInterestExpenseIncome
44339000
CY2021 mfin Net Income Loss Before Taxes
NetIncomeLossBeforeTaxes
81873000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24217000
CY2021 mfin Net Income Loss After Taxes
NetIncomeLossAfterTaxes
57656000
CY2021Q4 mfin Total Loans Net
TotalLoansNet
1438759000
CY2021Q4 us-gaap Assets
Assets
1873057000
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1485150000
CY2021 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0312
CY2021 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.2124
CY2021 mfin Interest Yield
InterestYield
0.1148
CY2021 mfin Net Interest Margin
NetInterestMargin
0.0926
CY2021 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0337
CY2021 mfin Delinquency Status
DelinquencyStatus
0.0028
CY2021 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
-0.0085
CY2020 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
144962000
CY2020 mfin Interest Expense Net
InterestExpenseNet
34151000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
110811000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
69817000
CY2020 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
40994000
CY2020 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
20042000
CY2020 mfin Race Team Related Expense
RaceTeamRelatedExpense
8366000
CY2020 mfin Non Interest Expense Income
NonInterestExpenseIncome
89651000
CY2020 mfin Net Income Loss Before Taxes
NetIncomeLossBeforeTaxes
-36981000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10074000
CY2020 mfin Net Income Loss After Taxes
NetIncomeLossAfterTaxes
-26907000
CY2020Q4 mfin Total Loans Net
TotalLoansNet
1172290000
CY2020Q4 us-gaap Assets
Assets
1642411000
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1312255000
CY2020 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
-0.0216
CY2020 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
-0.1090
CY2020 mfin Interest Yield
InterestYield
0.1132
CY2020 mfin Net Interest Margin
NetInterestMargin
0.0865
CY2020 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0468
CY2020 mfin Delinquency Status
DelinquencyStatus
0.0057
CY2020 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0500
CY2019 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
132562000
CY2019 mfin Interest Expense Net
InterestExpenseNet
35045000
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
97517000
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
47386000
CY2019 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
50131000
CY2019 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
18742000
CY2019 mfin Race Team Related Expense
RaceTeamRelatedExpense
8996000
CY2019 mfin Non Interest Expense Income
NonInterestExpenseIncome
57540000
CY2019 mfin Net Income Loss Before Taxes
NetIncomeLossBeforeTaxes
2337000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
341000
CY2019 mfin Net Income Loss After Taxes
NetIncomeLossAfterTaxes
1996000
CY2019Q4 mfin Total Loans Net
TotalLoansNet
1114762000
CY2019Q4 us-gaap Assets
Assets
1541667000
CY2019Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1169593000
CY2019 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
-0.0012
CY2019 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
-0.0059
CY2019 mfin Interest Yield
InterestYield
0.1175
CY2019 mfin Net Interest Margin
NetInterestMargin
0.0864
CY2019 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0397
CY2019 mfin Delinquency Status
DelinquencyStatus
0.0076
CY2019 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0360
CY2021 mfin Employment Agreement Description
EmploymentAgreementDescription
Employment agreements expire at various dates through 2026
CY2021Q4 mfin Employment Agreements Future Minimum Payments Due
EmploymentAgreementsFutureMinimumPaymentsDue
12100000
CY2021Q4 mfin Employment Agreements Future Minimum Payments Due Current
EmploymentAgreementsFutureMinimumPaymentsDueCurrent
3996000
CY2021Q4 mfin Employment Agreements Future Minimum Payments Due In Two Years
EmploymentAgreementsFutureMinimumPaymentsDueInTwoYears
2816000
CY2021Q4 mfin Employment Agreements Future Minimum Payments Due In Three Years
EmploymentAgreementsFutureMinimumPaymentsDueInThreeYears
2272000
CY2021Q4 mfin Employment Agreements Future Minimum Payments Due In Four Years
EmploymentAgreementsFutureMinimumPaymentsDueInFourYears
2094000
CY2021Q4 mfin Employment Agreements Future Minimum Payments Due In Five Years
EmploymentAgreementsFutureMinimumPaymentsDueInFiveYears
872000
CY2021Q4 mfin Employment Agreements Future Minimum Payments Due Thereafter
EmploymentAgreementsFutureMinimumPaymentsDueThereafter
0
CY2021Q4 mfin Employment Agreements Future Minimum Payments Due
EmploymentAgreementsFutureMinimumPaymentsDue
12050000
CY2021Q4 us-gaap Other Commitment
OtherCommitment
1800000
CY2022Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
239000
CY2020Q4 us-gaap Trading Liabilities Fair Value Disclosure
TradingLiabilitiesFairValueDisclosure
300
CY2021 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-1000000.0
CY2020 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
1000000.0
CY2018Q4 us-gaap Variable Interest Entity Initial Consolidation Gain Or Loss
VariableInterestEntityInitialConsolidationGainOrLoss
25300000
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
0

Files In Submission

Name View Source Status
0000950170-22-003603-index-headers.html Edgar Link pending
0000950170-22-003603-index.html Edgar Link pending
0000950170-22-003603.txt Edgar Link pending
0000950170-22-003603-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img207041141_0.jpg Edgar Link pending
img207041141_1.jpg Edgar Link pending
img207041141_2.jpg Edgar Link pending
img87478059_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mfin-20211231.htm Edgar Link pending
mfin-20211231.xsd Edgar Link pending
mfin-20211231_cal.xml Edgar Link unprocessable
mfin-20211231_def.xml Edgar Link unprocessable
mfin-20211231_htm.xml Edgar Link completed
mfin-20211231_lab.xml Edgar Link unprocessable
mfin-20211231_pre.xml Edgar Link unprocessable
mfin-ex10_48.htm Edgar Link pending
mfin-ex21_1.htm Edgar Link pending
mfin-ex23_1.htm Edgar Link pending
mfin-ex31_1.htm Edgar Link pending
mfin-ex31_2.htm Edgar Link pending
mfin-ex32_1.htm Edgar Link pending
mfin-ex32_2.htm Edgar Link pending
mfin-ex4_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending